当前位置: X-MOL首页全球导师 海外导师 › Speck, Peter

研究领域

Bacteria are becoming resistant to antibiotics. A strong potential alternative is bacteriophages -"phages" -viruses that infect bacteria. In collaboration with US/Australian company AmpliPhi Biosciences, I am pursuing the use of phages as a treatment for bacterial infections in a number of important medical settings: -chronic rhinosinusitis: a human trial of this technology commenced in January 2016, in collaboration with ENT surgeon/scientist Prof. PJ Wormald -diabetic foot ulcer infections -nasal Staphylococcus aureus decolonization. I collaborate with the US Army Medical Research Materiel Command to introduce phages into their Combat Wound Infection Control Program

近期论文

查看导师新发文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Speck, P.G. (2013). Antibiotics: Avert an impending crisis. Nature, 496(7444) pp. 169. [Scopus] [Web Link] [Web Link] Speck, P.G., Callen, D.F. and Longnecker, R. (2003). Absence of the Epstein-Barr virus genome in breast cancer-derived cell lines. Journal of The National Cancer Institute, 95(16) pp. 1253-1254. [10.1093/jnci/djg041] [Scopus]

推荐链接
down
wechat
bug